High exposure to nevirapine in plasma is associated with an improved virological response in HIV-1-infected individuals-Reference-Cited by-同舟云学术

High exposure to nevirapine in plasma is associated with an improved virological response in HIV-1-infected individuals

Published:2001-06 Issue:9 Volume:15 Page:1089-1095
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:AIDS

Author:

Veldkamp Agnes I.,Weverling Gerrit J.,Lange Joep M. A.,Montaner Julio S. G.,Reiss Peter,Cooper David A.,Vella Stefano,Hall David,Beijnen Jos H.,Hoetelmans Richard M. W.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference9 articles.

1. Drug Evaluations Anti-infectives: Nevirapine: A review of its development, pharmacological profile and potential for clinical use

2. High‐Dose Nevirapine in Previously Untreated Human Immunodeficiency Virus Type 1‐Infected Persons Does Not Result in Sustained Suppression of Viral Replication

3. High-Dose Nevirapine: Safety, Pharmacokinetics, And Antiviral Effect In Patients With Human Immunodeficiency Virus Infection

4. Antiviral Effect and Pharmacokinetic Interaction between Nevirapine and Indinavir in Persons Infected with Human Immunodeficiency Virus Type 1

5. The effect of plasma drug concentrations on HIV-1 clearance rate during quadruple drug therapy

Cited by 192 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nevirapine plasma concentration is associated with virologic failure and the emergence of drug-resistant mutations among HIV patients in Kenya: A cross sectional study;Medicine;2022-12-16

2. Association between social psychological status and efavirenz and nevirapine plasma concentration among HIV patients in Kenya;Scientific Reports;2021-11-11

3. Could pharmacogenetics aid the prediction of nevirapine pharmacokinetics and allow individualized treatment?;Pharmacogenomics;2021-09

4. Pharmacogenetic predictors of nevirapine pharmacokinetics in Ghanaian children living with HIV with or without TB coinfection;Infection, Genetics and Evolution;2021-08

5. The crosstalk between antiretrovirals pharmacology and HIV drug resistance;Expert Review of Clinical Pharmacology;2020-06-30